Dantrium Injection
Product Images NDC 42023-123

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dantrium (NDC 42023-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dantrium Iv 1)

Chemical structure of dantrolene sodium. The diagram shows the molecular configuration of dantrolene sodium, the active ingredient in Dantrium injection, with its distinctive aromatic rings and sodium salt moiety.*

FDA Label Image

Principal Display Panel (20 mg Vial Carton)

Label for Dantrium Intravenous injection containing dantrolene sodium, 20 mg per vial. The packaging states it is for treatment of malignant hyperthermia and for intravenous use only. Distributed by Par Pharmaceutical, the label includes preparation instructions and storage information. The product is Rx only and contains 6 nonreturnable vials.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.